Tech Company Financing Transactions

Amylyx Pharmaceuticals Funding Round

Amylyx Pharmaceuticals secured a $135 million Series C financing round on 7/21/2021. Investors included Viking Global Investors, 683 Capital and Alpha Wave Ventures.

Transaction Overview

Announced On
7/21/2021
Transaction Type
Venture Equity
Amount
$135,000,000
Round
Series C
Proceeds Purpose
The company intends to use the funds for the clinical development and potential launch plans for lead product candidate AMX0035, for the potential treatment of ALS, and further research and development in other neurodegenerative diseases.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
43 Thorndike St.
Cambridge, MA 02141
USA
Phone
Undisclosed
Email Address
Overview
Amylyx is an IND-enabling stage biopharmaceutical company dedicated to providing innovative, disease-modifying solutions for neurodegenerative diseases. We have a highly creative and motivated team focused on streamlined clinical development and drug discovery.
Profile
Amylyx Pharmaceuticals LinkedIn Company Profile
Social Media
Amylyx Pharmaceuticals Company Twitter Account
Company News
Amylyx Pharmaceuticals News
Facebook
Amylyx Pharmaceuticals on Facebook
YouTube
Amylyx Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joshua Cohen
  Joshua Cohen LinkedIn Profile  Joshua Cohen Twitter Account  Joshua Cohen News  Joshua Cohen on Facebook
Chief Executive Officer
Justin Klee
  Justin Klee LinkedIn Profile  Justin Klee Twitter Account  Justin Klee News  Justin Klee on Facebook
Chief Financial Officer
James Frates
  James Frates LinkedIn Profile  James Frates Twitter Account  James Frates News  James Frates on Facebook
Chief Medical Officer
Patrick Yeramian
  Patrick Yeramian LinkedIn Profile  Patrick Yeramian Twitter Account  Patrick Yeramian News  Patrick Yeramian on Facebook
Chief Scientific Officer
Kent Leslie
  Kent Leslie LinkedIn Profile  Kent Leslie Twitter Account  Kent Leslie News  Kent Leslie on Facebook
VP - Bus. Development
Margaret Olinger
  Margaret Olinger LinkedIn Profile  Margaret Olinger Twitter Account  Margaret Olinger News  Margaret Olinger on Facebook
VP - Human Resources
Debra Canner
  Debra Canner LinkedIn Profile  Debra Canner Twitter Account  Debra Canner News  Debra Canner on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/21/2021: Titan Global Capital Management venture capital transaction
Next: 7/21/2021: Inkbit venture capital transaction

 

Share this article

 


About Database of VC Transactions

We record every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary